tiprankstipranks
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market
LEXX
Lexaria Bioscience
RESEARCH TOOLSreports
Want to see LEXX full AI Analyst Report?

Lexaria Bioscience (LEXX) Ratios

245 Followers

Lexaria Bioscience Ratios

LEXX's free cash flow for Q2 2026 was $-0.33. For the 2026 fiscal year, LEXX's free cash flow was decreased by $ and operating cash flow was $-72.60. See a summary of the company’s cash flow.
Ratios
TTM
Aug 25Aug 24Aug 23Aug 22
Liquidity Ratios
Current Ratio
 26.88 2.32 7.18 8.22 35.96
Quick Ratio
 26.88 2.32 7.18 8.22 35.76
Cash Ratio
 23.89 1.21 5.91 5.05 29.96
Solvency Ratio
 -34.09 -7.50 -4.73 -16.14 -35.36
Operating Cash Flow Ratio
 -43.67 -7.00 -4.51 -21.97 -25.15
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 5.49M$ 1.90M$ 6.69M$ 1.80M$ 6.78M
Leverage Ratios
Debt-to-Assets Ratio
 0.01 0.03 0.02 0.05 <0.01
Debt-to-Equity Ratio
 0.01 0.04 0.02 0.05 <0.01
Debt-to-Capital Ratio
 0.01 0.04 0.02 0.05 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 0.98 1.40 1.10 1.01 0.99
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 0.01 0.02 <0.01
Net Debt to EBITDA
 0.53 0.14 1.11 0.18 0.80
Profitability Margins
Gross Profit Margin
76.20%83.20%82.56%23.86%18.29%
EBIT Margin
-2591.15%-1687.36%-1251.12%-2967.41%-2891.06%
EBITDA Margin
-2567.35%-1670.94%-1234.71%-2903.14%-2833.54%
Operating Profit Margin
-2513.78%-1647.97%-1226.70%-2888.50%-2545.40%
Pretax Profit Margin
-2590.67%-1687.36%-1251.12%-2967.41%-2891.06%
Net Profit Margin
-2589.65%-1686.00%-1248.25%-2946.36%-2846.30%
Continuous Operations Profit Margin
-2591.12%-1687.36%-1251.12%-2967.41%-2891.06%
Net Income Per EBT
99.96%99.92%99.77%99.29%98.45%
EBT Per EBIT
103.06%102.39%101.99%102.73%113.58%
Return on Assets (ROA)
-146.90%-285.07%-65.35%-216.11%-92.79%
Return on Equity (ROE)
-190.06%-398.10%-72.11%-218.94%-91.45%
Return on Capital Employed (ROCE)
-147.48%-433.81%-73.31%-232.01%-85.09%
Return on Invested Capital (ROIC)
-146.73%-428.95%-73.05%-229.74%-84.62%
Return on Tangible Assets
-154.47%-307.76%-69.40%-254.25%-98.96%
Earnings Yield
-56.59%-75.12%-11.97%-95.97%-41.73%
Efficiency Ratios
Receivables Turnover
 8.76 1.92 3.01 1.29 1.27
Payables Turnover
 2.42 0.09 0.08 0.77 1.74
Inventory Turnover
 0.00 0.00 0.00 0.00 5.43
Fixed Asset Turnover
 1.10 2.11 1.19 0.54 0.69
Asset Turnover
 0.06 0.17 0.05 0.07 0.03
Working Capital Turnover Ratio
 0.08 0.16 0.11 0.05 0.03
Cash Conversion Cycle
 -109.15 -4.01K -4.65K -194.10 145.43
Days of Sales Outstanding
 41.69 190.46 121.44 282.77 288.38
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 67.20
Days of Payables Outstanding
 150.84 4.20K 4.77K 476.87 210.14
Operating Cycle
 41.69 190.46 121.44 282.77 355.58
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.38 -0.58 -0.40 -0.89 -0.83
Free Cash Flow Per Share
 -0.39 -0.58 -0.40 -0.91 -0.84
CapEx Per Share
 <0.01 <0.01 <0.01 0.03 <0.01
Free Cash Flow to Operating Cash Flow
 1.01 1.00 1.01 1.03 1.01
Dividend Paid and CapEx Coverage Ratio
 -167.68 -424.07 -115.28 -34.68 -99.19
Capital Expenditure Coverage Ratio
 -167.68 -424.07 -115.28 -34.68 -99.19
Operating Cash Flow Coverage Ratio
 -99.32 -95.59 -36.10 -35.87 -97.61
Operating Cash Flow to Sales Ratio
 -25.47 -14.80 -10.68 -26.00 -19.10
Free Cash Flow Yield
-66.96%-66.11%-10.33%-87.13%-28.29%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.69 -1.33 -8.36 -1.04 -2.40
Price-to-Sales (P/S) Ratio
 36.61 22.44 104.29 30.70 68.21
Price-to-Book (P/B) Ratio
 2.44 5.30 6.03 2.28 2.19
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.43 -1.51 -9.68 -1.15 -3.53
Price-to-Operating Cash Flow Ratio
 -1.72 -1.52 -9.76 -1.18 -3.57
Price-to-Earnings Growth (PEG) Ratio
 -0.09 -0.03 0.16 0.06 -0.07
Price-to-Fair Value
 2.44 5.30 6.03 2.28 2.19
Enterprise Value Multiple
 -0.89 -1.20 -7.34 -0.88 -1.61
Enterprise Value
 9.05M 14.15M 42.06M 5.76M 11.66M
EV to EBITDA
 -0.96 -1.20 -7.34 -0.88 -1.61
EV to Sales
 24.59 20.05 90.59 25.45 45.64
EV to Free Cash Flow
 -0.96 -1.35 -8.41 -0.95 -2.37
EV to Operating Cash Flow
 -0.97 -1.35 -8.48 -0.98 -2.39
Tangible Book Value Per Share
 0.24 0.13 0.58 0.34 1.21
Shareholders’ Equity Per Share
 0.27 0.17 0.65 0.46 1.35
Tax and Other Ratios
Effective Tax Rate
 >-0.01 0.00 0.00 0.00 0.00
Revenue Per Share
 0.02 0.04 0.04 0.03 0.04
Net Income Per Share
 -0.39 -0.66 -0.47 -1.01 -1.24
Tax Burden
 1.00 1.00 1.00 0.99 0.98
Interest Burden
 1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
 15.62 11.67 5.08 16.21 7.21
SG&A to Revenue
 10.28 5.64 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 2.02 1.22 1.06 0.75 2.95
Income Quality
 0.98 0.88 0.85 0.88 0.66
Currency in USD